CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $27,727,000 | +16.4% | 245,151 | +3.1% | 0.01% | +10.0% |
| Q1 2017 | $23,819,000 | -2.1% | 237,885 | +5.1% | 0.01% | -9.1% |
| Q4 2016 | $24,340,000 | -9.6% | 226,378 | 0.0% | 0.01% | -15.4% |
| Q3 2016 | $26,915,000 | +22.6% | 226,378 | +9.7% | 0.01% | +30.0% |
| Q2 2016 | $21,947,000 | +15.5% | 206,428 | +24.3% | 0.01% | +11.1% |
| Q1 2016 | $19,004,000 | -2.0% | 166,007 | +22.0% | 0.01% | -10.0% |
| Q4 2015 | $19,390,000 | +417.8% | 136,107 | +226.4% | 0.01% | +400.0% |
| Q3 2015 | $3,745,000 | – | 41,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
| WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
| RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
| INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
| Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
| Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
| Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
| BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
| Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |